Ergotron (PRIVATE.ERGOTRON)

Overall impact
B (66)

Commentary

Ergotron is a strong overall performer. With a 'B' rating of 65.9 for overall impact (74th percentile compared to all companies), Ergotron ranks 111th out of 204 industry peers, behind Restoration Robotics, Corindus Vascular Robotics, Modular Medical and 107 others, and ahead of Medtronic, Axonics Modulation Technologies, Star Equity Holdings and 90 others. On top material causes for Ergotron's industry (Health Care Equipment & Supplies), Ergotron performs well in Disease Eradication (82.7 score), Accountable Institutions (91.3), Accountable Institutions (91.3) and 12 other causes where it received an 'A' score and performs poorly in Child and Maternal Health (36.3 score), Child and Maternal Health (37.4), Accountable Institutions (29.9) and 41 other causes where it received a 'D' or 'F' score.
Screens
Fur
Impact
Cause PRIVATE.ERGOTRON
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1982
Employees
1,300
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Electrical & Electronic Equipment
Headquarters
Minnesota, United States
Share classes
PRIVATE.ERGOTRON
Description
Manufacturer of digital display mounting and mobility products for computer monitors, notebooks, and flat panel displays. The company's ergonomic products provide mobile digital platforms for classrooms in K-12 primary and secondary schools, as well as private and public colleges and universities for collaborative learning environments.This enables users to bring comfort, wellness, and improved productivity into the workplace.
Material causes
Ethos considers the following causes material for Ergotron, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.